Physician profile
Andrea M Pakula
NPI 1568767960
$1,401,005.93
in general payments reported to CMS, 2019-2025
17 companies · $265K in 2025
The $265K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $88K · 2021: $140K · 2022: $263K · 2023: $236K · 2024: $300K · 2025: $265K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $408K · Education: $300K · Travel and Lodging: $38K · Honoraria: $31K · Food and Beverage: $22K · Consulting Fee: $1,100 · Gift: $84.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $408,060.00 |
| Education | $299,743.11 |
| Travel and Lodging | $38,246.38 |
| Honoraria | $31,410.00 |
| Food and Beverage | $21,593.84 |
| Consulting Fee | $1,100.00 |
| Gift | $84.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,255,298.58 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Davol INC. | $110,669.91 | 2019-2025 | Phasix Mesh, Arista, Arista Ah Flexitip |
| Medtronic, INC. | $32,395.75 | 2021-2025 | Progrip, Absorbatack, Dextile |
| C. R. Bard, INC. & Subsidiaries | $1,168.50 | 2019-2022 | |
| Tela Bio, INC. | $537.17 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $444.23 | 2022-2025 | Airseal, Visiclear, System 2450 |
| Osiris Therapeutics INC. | $123.08 | 2019 | |
| Covidien Lp | $119.19 | 2019 | |
| Baxter Healthcare | $60.04 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $38.43 | 2021-2022 | |
| Endo USA, INC. | $26.32 | 2025 | Xiaflex |
| Novo Nordisk INC | $26.00 | 2022 | |
| Solventum Corporation | $23.07 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Mimedx Group, INC. | $20.45 | 2025 | |
| Becton, Dickinson and Company | $19.90 | 2025 | Arista |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $19.49 | 2025 | |
| Intra-Sana Laboratories | $15.82 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Pakula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.